FDA applicant
Medeon Biodesign, Inc.
FDA records 7 decisions for Medeon Biodesign, Inc. (Taipei, TW) from 2015 to 2020: 7 510(k) clearances. Most are in product codes GCJ (Laparoscope, General & Plastic Surgery) and OCW (Endoscopic Tissue Approximation Device). Since 2016 its 510(k)s took a median of 32 days from receipt to decision, against 69 for FDA’s reviews in the same codes and years. Its devices cite 7 predicates, 5 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Medeon Biodesign, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2020
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2015.
Planning a device like Medeon Biodesign, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report